Synergy Introduces New "HALO" Connected VTE Prevention Device with an Associated Compliance Management Program
The first-ever patented SCD Bluetooth Monitoring Solution for DVT by Synergy DMEPOS, the leader in DVT/VTE Preventive Care Programs.
With the National expansion of our two innovative Value Based Preventive Care Programs
Synergy DMEPOS is excited to introduce a new compliance management service as a component of our VTE Prevention Programs. We are in the process of incorporating this new offering within our Post-Acute VTE Prevention and MomWell Care Kit Programs.
This service remotely monitors utilization of the connected "HALO" intermittent pneumatic compression devices (IPCDs) and promotes adherence to usage protocols through direct patient intervention and the provision of compliance reporting for providers.
MomWell Pregnancy Care Kit
Synergy's clinically developed pregnancy care kit, focused on comfort and prevention during and postpartum pregnancy.
Post Acute Hospital Discharge
Synergy's "Post Acute Discharge program focuses on preventive patient DVT care upon hospital discharge.
Synergy DMEPOS is proud to announce our "HALO"
the world’s first Bluetooth DVT Prevention and Monitoring solution
While the industry continues to rely on outdated technology
Synergy is pioneering the first ever Bluetooth DVT Monitoring System, strongly focusing on patient compliance, provider outreach, and payer efficacy.
The "HALO" Dashboard
The "HALO" has a patient-facing and provider-facing dashboard, creating a simple, easy-to-use platform for both physicians and patients.
Our new state-of-the-art, patented "HALO" intermittent pneumatic compression unit is a battery-operated, Bluetooth-enabled device with connectivity to the Synergy DME "HALO" application.
Our comprehensive App collects key data points and provides the ability to communicate directly with the product end user, delivering educational compliance messaging as determined appropriate.
Why should your organization adopt the Synergy DMEPOS VTE Prevention Program?
The direct cost of VTE annually in the US is approximately $12.5 to $66 billion per year.
Of this total cost, a minimum of $4.6 to $34.9 billion per year is considered preventable costs.
Synergy DMEPOS is offering our partner health plans the opportunity of implementing this new, value-based program to assist in reducing the occurrence of VTE in various member populations, to meet plan objectives of improving overall health outcomes of members, and to reduce the initial and downstream costs associated with VTE.
By implementing an effective, non-pharmacologic, VTE prevention program that utilizes mechanical thromboprophylaxis mimicking the natural motion of ambulating, complications such as the risk of bleeding may be avoided while proactively employing preventative measures. In addition, the Synergy "Halo" device and corresponding intervention program offers the opportunity to maximize the efficacy of this non-invasive, preventive program.
The Synergy DMEPOS "HALO" simplifies remote patient monitoring with real-time compliance tracking, comprehensive reporting, and SMS push notification messaging, empowering surgeons with actionable insights, all while collecting invaluable data for our PAYER partners interested in improving their VALUE BASED programs for DVT.
The Halo is a physician-prescribed, user-friendly mechanical compression solution designed for home use to help prevent DVT.
This tubeless, cordless device supports post-surgical DVT prevention while reducing fall risks and enhancing patient compliance. Its mobile design ensures ease of use in recovery settings, and its proprietary compliance software allows for seamless patient monitoring.
Patient Dashboard APPThe HALO App is the pioneering patient monitoring solution designed to assist patients throughout their DVT prevention journey. It tracks device usage and delivers valuable clinical data directly to healthcare providers for enhanced care.
- Provider Dashboard
Major payor groups recognize the importance of digital devices that enable physicians to access patient-centered information for remote evaluations. Our patented solution combines a mobile DVT device with a patient-facing app, offering our surgeon partners real-time insights into their patients' DVT status, even when they're at home.
- Real-Time Report Automation
As technology advances and data collection becomes more widespread, it can sometimes feel overwhelming. That's why we've created an automated solution that delivers the essential data you need, directly at your fingertips. This approach reduces the complexity of technology while enhancing both the patient and surgeon experience.
- Home Recovery Risk
Protocols have evolved, and patients now require treatment during their recovery at home. PreVent offers enhanced visibility, ensuring patients receive the highest standard of care even while at home.
Next-Level
Standard
Track Treatment
Compliance
Track DVT
Incidents
Enhance Patient
Security
Smart Reporting
Automation
DVT Education
Management
Physician risk exposure is a real concern, with DVT litigation on the rise. Our protocol-based standard of care provides surgeon partners with the most efficient solution for preventing blood clots after surgery.
34% of physicians have faced a medical liability lawsuit at some point in their careers.
DVT risk is exposed in two ways: by adhering to the appropriate standard of care under the given circumstances, and by breaching that standard of care.
Compliance is shaping the industry efforts are underway to monitor patient compliance, with current data revealing a growing issue. Our compliance solution offers the visibility necessary to improve patient care.
34% of physicians have faced a medical liability lawsuit at some point in their careers.
DVT risk is exposed in two ways: by adhering to the appropriate standard of care under the given circumstances, and by breaching that standard of care.
- As many as 53% of patients studied fail to follow prescribed anticoagulant usage.
- Fewer than 25% of patients fail to comply with wearing mechanical prophylaxis during their hospital stay.
- There is no visibility into the usage or compliance with prophylactic treatment at home.
The Halo is launching soon, and we’re always seeking forward-thinking surgeons who prioritize the Standard of Care for their patients. Contact us below to learn more about our upcoming New Standard of Care for DVT Prevention and our DIRECT payer partnerships who have adopted our post-acute discharge program as a value-based program.
Patient Adherence to Novel Oral Anticoagulants (NOACs) for the Treatment of Atrial Fibrillation and Occurrence of Associated Bleeding Events: A Systematic Reviewand Meta-analysis. Curr Vasc Pharmacol. 2019;17(4):341-349 Deep Vein Thrombosis(DVT) Caused By Negligent Medical Care. Andrew Suszek Assessment of 30-day mortality and complication rates associated with extended deep veinthrombosis prophylaxis following hip fracture surgery. Injury. 2018Jun;49(6):1141-1148. Prevention of VTE in Orthopedic Surgery Patients. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Thromboprophylaxisin orthopedic surgery: how long is long enough? Am J Orthop (Belle Mead NJ).2009
Aug;38(8):394-401. New forAmbulatory Care: National Patient Safety Goal Addresses Direct Oral Anticoagulants. 02/06/2019. By Helen Larios MBA, MSN, RN, ProjectDirector-Clinical, Department of Standards and Survey Methods Policy ResearchPerspectives. Medical Liability Claim Frequency Among U.S. Physicians. By José R. Guardado, PhD. American Medical Association. Guideline ForPrevention of Venous Thromboembolism. 2019 Guidelines for Perioperative Practice. AORN
